Carvedilol Tablet, Film Coated
Product Images NDC 0615-8387

13 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 0615-8387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Carvedilol (Carvedilol Tabs 8387 8388 8389 8390 1)

Structural Formula For Carvedilol (Carvedilol Tabs 8387 8388 8389 8390 1)
Chemical structure of Carvedilol, showing its molecular framework with indole and phenyl groups along with hydroxyl, methoxy, and amine functional groups.*
FDA Label Image

Figure 1 (Carvedilol Tabs 8387 8388 8389 8390 2)

Figure 1 (Carvedilol Tabs 8387 8388 8389 8390 2)
A line graph depicting mortality percentage over time in months for two groups labeled Carvedil and Placebo. The graph shows lower mortality for the Carvedil group compared to Placebo, with a p-value of 0.0014 indicated, suggesting statistical analysis of mortality outcomes over approximately 21 months.*
FDA Label Image

Figure 2 (Carvedilol Tabs 8387 8388 8389 8390 3)

Figure 2 (Carvedilol Tabs 8387 8388 8389 8390 3)
A forest plot displaying hazard ratios for various patient groups including men, women, different age ranges, racial groups, diabetic status, ischemic conditions, heart rate categories, systolic blood pressure levels, and spironolactone use. The horizontal axis represents hazard ratios from 0 to 2.0 with confidence intervals shown as horizontal lines around each point estimate. The plot compares risk levels across these subgroups.*
FDA Label Image

Figure 3 (Carvedilol Tabs 8387 8388 8389 8390 4)

Figure 3 (Carvedilol Tabs 8387 8388 8389 8390 4)
A line graph comparing the percentage mortality over 24 months between two groups: placebo and Carvedilol. The X-axis represents time in months, and the Y-axis shows percent mortality. The Carvedilol group consistently shows lower mortality rates than the placebo group, with a p-value of 0.03 indicating statistical significance.*
FDA Label Image

Figure 4 (Carvedilol Tabs 8387 8388 8389 8390 5)

Figure 4 (Carvedilol Tabs 8387 8388 8389 8390 5)
A forest plot illustrating hazard ratios for various patient subgroups based on characteristics such as age, gender, timing post-myocardial infarction (MI), prior intravenous or oral beta-blocker use, Killip classification, thrombolytic therapy, percutaneous transluminal coronary angioplasty (PTCA) for MI, congestive heart failure status, diuretic use, angina presence, hypertension status, diabetes, heart rate, and systolic blood pressure (SBP). Each subgroup shows a point estimate and confidence interval around a hazard ratio axis ranging from 0.4 to 1.3.*
FDA Label Image

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 6)

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 6)
Carton label for Carvedilol Tablets USP 3.125 mg, film-coated tablets for oral use. The label shows the NDC number 0093-0051-05, lot number 8387, and a quantity of 30 tablets. It is manufactured by Piramal for Teva and packaged by Vangard Labs in Glasgow, KY. The label includes storage instructions, barcodes, and a note "For Institutional Use Only."*
FDA Label Image

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 7)

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 7)
Carvedilol 3.125 mg tablet label sheet with multiple individual labels showing the drug name, strength, lot number 8387, and barcode. The label includes storage instructions to store at 20°-25°C, dispense in a tight, light-resistant container, and protect from moisture. The packaging is for Carvedilol tablets, USP 3.125 mg, quantity 30, repackaged by Vangard Labs, Glasgow, KY, and manufactured by Piramal for Teva.*
FDA Label Image

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 8)

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 8)
Label for Carvedilol Tablets USP 6.25 mg, film-coated tablets for oral use. The label includes multiple barcodes, lot number 8388-, and manufacturer information: Mfg by Piramal for Teva, packaged by Vangard Labs, Glasgow, KY 42141. The label states that each tablet contains 6.25 mg carvedilol USP and advises storage at 20° to 25°C. The package quantity is 30 tablets, and the label is marked for institutional use only.*
FDA Label Image

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 9)

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 9)
Label sheet for Carvedilol Tablets USP 6.25 mg film-coated tablets. The label includes multiple small barcode stickers each showing 'Carvedilol Tab USP 6.25 mg' with lot number and barcode. At the bottom, larger label panels indicate the product name, strength, quantity of 30 tablets, manufacturer Piramal, repackaged by Vangard Labs, Glasgow, KY. The label details storage instructions at 20° to 25°C (68° to 77°F).*
FDA Label Image

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 10)

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 10)
Carvedilol tablet label for 12.5 mg film-coated tablets. The label includes multiple barcodes for individual tablets, lot number 8389, and storage instructions. The label indicates it is for institutional use only and provides manufacturer and packager information: manufactured by Piramal for Teva, packaged by Vangard Labs, Glasgow, KY. It includes dosage and handling notes consistent with USP standards.*
FDA Label Image

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 11)

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 11)
Label sheet for Carvedilol tablet USP 12.5 mg by NCS HealthCare of KY, LLC dba Vangard Labs. The individual tablet labels feature the product name, strength, lot number placeholder, and barcode. The larger main label shows Carvedilol Tablets USP 12.5 mg, a quantity of 30 tablets, storage instructions, manufacturer Piramal for Teva, and repackager Vangard Labs, Glasgow, KY, with associated barcodes.*
FDA Label Image

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 12)

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 12)
Carvedilol Tablets USP 25 mg film-coated tablets packaging label showing manufacturer information for Teva and packaging by Vangard Labs, Glasgow, KY. The label includes lot number, quantity of 30 tablets, storage instructions, barcode, and a section marked for institutional use only with multiple smaller labels for individual tablets.*
FDA Label Image

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 13)

Principal Display Panel (Carvedilol Tabs 8387 8388 8389 8390 13)
Carvedilol tablets USP 25 mg film-coated tablet labels. The top section shows multiple identical barcoded labels for Carvedilol 25 mg, indicating the package by Vangard Labs in Glasgow, KY. Below are additional detailed labels for Carvedilol Tablets USP 25 mg, including quantity (30 tablets), storage instructions, manufacturer (Piramal for Teva), and repackaging information by Vangard Labs.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.